Articles for Mediclinic International (LSE: MDC)

Is the RBS share price or this falling FTSE 250 knife the brighter bargain today?

Royal Bank of Scotland plc's (LON: RBS) share price looks attractive, but this FTSE 250 (INDEXFTSE: UKX) turnaround could be a better buy. More »

Why I think it’s time to buy this FTSE 100 stock, down 25% in two months

Rupert Hargreaves discusses the valuation and prospects of a fallen FTSE 100 (INDEXFTSE: UKX) flyer and a savaged mid-cap with a trading update out... More »

This FTSE 100 growth stock looks a far safer bet than bitcoin

If you're thinking of investing in bitcoin, here's a FTSE 100 (INDEXFTSE: UKX) growth candidate that could be a lot less risky. More »

Is the Mediclinic International share price a FTSE 100 bargain or a value trap?

Rupert Hargreaves considers whether FTSE 100 (INDEXFTSE: UKX) hospital giant Mediclinic International plc (LON: MDC) deserves a place in your portfolio. More »

Mediclinic International: a top FTSE 100 healthcare stock?

Mediclinic International plc (LON: MDC) shares are up 5% today. Are they worth a closer look? More »

Is Burberry Group plc a top Footsie turnaround buy today?

G A Chester evaluates Burberry Group plc (LON:BRBY) and another FTSE 100 (INDEXFTSE: UKX) turnaround prospect. More »

Why I’d sell this turnaround stock to buy a ‘secret’ FTSE 100 growth stock

From small-caps to the FTSE 100 (INDEXFTSE: UKX), there are growth opportunities to be found everywhere. More »

Why I’d buy this dividend stock over Barclays plc

Barclays plc's (LON: BARC) dividend potential is limited. This stock is a better buy. More »

Why I’d sell this FTSE 100 growth stock for its rival’s big dividend

This growth stock's lofty valuation has me looking at its FTSE 100 (INDEXFTSE: UKX) peer's 3.9% yield and more reasonable valuation. More »

2 FTSE 100 growth stocks you can retire on

These two defensive growth champions could be great investments for retirement. More »

2 super growth stocks you need to check out today

Royston Wild considers the growth outlook of two mid-week newsmakers. More »

Is Mediclinic International plc a screaming buy as shares surge 20% higher?

Regulatory rollbacks send shares of Mediclinic International plc (LON: MDC) soaring 20%. Time to buy? More »

2 growth stars set to beat the FTSE 100

These two companies appear to have relatively low valuations given their growth prospects. More »

Could South Africa’s junk status trash these 3 stocks?

Troubles in South Africa have hit home for these three UK-listed stocks, says Harvey Jones. More »

4 stocks I’d buy near 52-week lows

The only way is up for these for bottom scrapers, says Harvey Jones. More »

Over 15% upside by 2019 despite profit warning sending this stock 7% lower

This stock could be worth buying even after a profit warning. More »

Beat the January sales with these blue-chip bargains

Bilaal Mohamed spots two blue-chip bargains that could post healthy gains in 2017. More »

These FTSE 100 stocks sank in Q4. Can they rebound in 2017?

Royston Wild considers the share price outlook of two FTSE 100 (INDEXFTSE: UKX) crashers. More »

Which of these Footsie healthcare stars should you buy after today’s news?

Royston Wild discusses the investment prospects of two Footsie medical giants. More »

Are these FTSE 100 fallers poised to bounce back?

Royston Wild considers the rebound potential of two FTSE 100 (INDEXFTSE: UKX) giants. More »